tradingkey.logo
tradingkey.logo
Search

ADC Therapeutics SA

ADCT
Add to Watchlist
1.150USD
-0.045-3.69%
Close 07-24 16:00ETQuotes delayed by 15 min
146.27MMarket Cap
LossP/E TTM

ADCT Financials

See ADC Therapeutics SA's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ADC Therapeutics SA Earnings Date

Latest Release
May 4, 2026
EPS / Forecast
-0.21/-0.22
Revenue / Forecast
20.85M/19.24M
Period
FY2025 Earnings
Revenue(YoY)
81.36M
14.85%
EPS(YoY)
-1.12
30.91%
Analyst Rating
BUY
2026/07/25
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Financial Indicators
EPS
40.60%-0.21
85.39%-0.04
13.28%-0.36
-30.41%-0.50
36.22%-0.36
71.80%-0.29
26.16%-0.42
36.40%-0.38
23.23%-0.56
---1.03
---0.57
---0.60
---0.74
----
---1.70
----
----
----
----
----
----
----
Revenue
-9.47%20.85M
36.36%23.06M
-11.03%16.43M
8.21%18.84M
27.59%23.03M
0.71%16.91M
27.40%18.46M
-9.71%17.41M
-4.94%18.05M
--16.79M
-81.01%14.49M
11.52%19.28M
-59.16%18.99M
----
480.52%76.32M
359.87%17.29M
--46.50M
--17.01M
--13.15M
--3.76M
----
----
Net Profit
14.60%-32.97M
79.14%-6.41M
6.83%-40.97M
-55.01%-56.65M
17.17%-38.60M
63.86%-30.73M
5.90%-43.97M
25.30%-36.54M
21.57%-46.61M
---85.03M
7.67%-46.73M
24.00%-48.92M
-256.68%-59.43M
----
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
38.53%-34.38M
-251.97%-71.55M
42.66%-72.57M
-18.52%-51.53M
----
Net Margin
5.66%-158.11%
84.70%-27.80%
-4.72%-249.38%
-43.25%-300.68%
35.08%-167.59%
64.12%-181.71%
26.14%-238.13%
17.27%-209.90%
17.49%-258.16%
---506.44%
---322.40%
---253.71%
---312.90%
----
---93.96%
----
----
----
----
----
----
----
Gross Margin
-9.21%82.66%
0.80%92.63%
-2.84%92.68%
2.74%95.56%
5.76%91.05%
-0.93%91.89%
-3.22%95.39%
-1.19%93.01%
-11.84%86.10%
--92.76%
--98.56%
--94.13%
--97.66%
----
--98.96%
----
----
----
----
----
----
----
Debt to assets ratio
-10.80%144.21%
0.61%135.53%
25.59%157.16%
20.41%139.23%
17.64%161.67%
14.80%134.71%
--125.13%
--115.63%
89.32%137.43%
78.84%117.34%
----
----
--72.59%
--65.61%
--61.09%
----
----
----
----
----
----
----
Revenue
-9.47%20.85M
36.36%23.06M
-11.03%16.43M
8.21%18.84M
27.59%23.03M
0.71%16.91M
27.40%18.46M
-9.71%17.41M
-4.94%18.05M
--16.79M
-81.01%14.49M
11.52%19.28M
-59.16%18.99M
----
480.52%76.32M
359.87%17.29M
--46.50M
--17.01M
--13.15M
--3.76M
----
----
Operating profit
11.31%-25.25M
43.68%-18.27M
13.98%-30.59M
-6.94%-31.06M
15.32%-28.46M
18.87%-32.44M
1.62%-35.56M
26.75%-29.04M
33.68%-33.61M
---39.98M
-1440.22%-36.15M
40.92%-39.65M
-24.45%-50.68M
----
95.96%-2.35M
13.10%-67.11M
42.37%-40.73M
18.17%-63.83M
-10.80%-58.09M
-71.83%-77.23M
-61.02%-70.67M
----
Net Profit
14.60%-32.97M
79.14%-6.41M
6.83%-40.97M
-55.01%-56.65M
17.17%-38.60M
63.86%-30.73M
5.90%-43.97M
25.30%-36.54M
21.57%-46.61M
---85.03M
7.67%-46.73M
24.00%-48.92M
-256.68%-59.43M
----
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
38.53%-34.38M
-251.97%-71.55M
42.66%-72.57M
-18.52%-51.53M
----
Current assets
7.28%276.77M
-0.34%306.33M
-13.77%287.15M
-10.30%318.75M
-11.10%257.99M
-8.59%307.39M
--333.00M
--355.36M
-23.63%290.21M
-22.69%336.29M
----
----
-22.08%380.01M
-17.18%434.98M
-22.93%438.10M
7.61%424.44M
24.02%487.71M
16.59%525.18M
12.24%568.41M
9.83%394.43M
--393.24M
267.40%450.45M
Total current liabilities
17.02%67.63M
-12.81%70.16M
-8.33%62.04M
12.09%64.60M
-8.24%57.79M
18.91%80.47M
--67.68M
--57.63M
-22.32%62.98M
-17.41%67.67M
----
----
14.57%81.09M
10.83%81.94M
47.68%87.57M
43.08%73.68M
70.96%70.77M
82.84%73.94M
82.11%59.30M
64.18%51.50M
--41.40M
102.76%40.44M
Total assets
6.96%291.50M
0.36%323.15M
-16.99%289.76M
-13.51%321.56M
-11.50%272.54M
-9.25%321.98M
--349.08M
--371.78M
-34.15%307.97M
-27.72%354.78M
----
----
-19.63%467.67M
-20.57%490.86M
-16.65%531.76M
12.08%520.46M
26.03%581.89M
20.30%617.97M
22.33%637.98M
24.22%464.39M
--461.70M
273.10%513.69M
Total liabilities
-0.57%507.87M
-2.98%508.98M
1.33%527.94M
3.44%520.75M
1.66%510.76M
4.29%524.62M
--521.02M
--503.45M
16.84%502.42M
22.27%503.03M
----
----
2.57%429.99M
-8.96%411.41M
-5.26%426.98M
83.75%405.12M
156.03%419.22M
153.60%451.88M
209.81%450.67M
24.18%220.47M
--163.74M
571.74%178.19M
Total equity
9.17%-216.38M
8.29%-185.83M
-38.52%-238.18M
-51.28%-199.18M
-22.51%-238.22M
-36.69%-202.64M
---171.95M
---131.67M
-615.99%-194.45M
-286.59%-148.25M
----
----
-76.83%37.69M
-52.16%79.45M
-44.06%104.78M
-52.71%115.35M
-45.41%162.67M
-50.50%166.09M
-50.19%187.31M
24.26%243.92M
--297.97M
201.83%335.50M
Net operating income
47.26%-29.71M
-42.43%-31.12M
-18.32%-29.63M
26.66%-24.09M
-27.76%-56.33M
30.92%-21.85M
31.71%-25.04M
---32.84M
-198.52%-44.09M
---31.63M
-1770.75%-36.67M
----
56.40%-14.77M
----
103.75%2.19M
8.62%-53.01M
38.56%-33.88M
-19.22%-61.63M
-32.11%-58.59M
---58.01M
---55.15M
-53.60%-51.69M
Net investment
87.88%-32.00K
832.22%659.00K
100.00%0.00
100.00%0.00
50.28%-264.00K
72.48%-90.00K
67.32%-216.00K
---30.00K
47.74%-531.00K
---327.00K
-160.24%-661.00K
----
29.83%-1.02M
----
89.14%-254.00K
75.81%-689.00K
-120.40%-1.45M
-4.67%-830.00K
-66.88%-2.34M
---2.85M
---657.00K
-169.73%-793.00K
Net financing
-315.13%-583.00K
5197.23%57.09M
77.47%-198.00K
-4.98%93.78M
-23.88%271.00K
-111900.00%-1.12M
-351.86%-879.00K
--98.70M
281.63%356.00K
---1.00K
-85.24%349.00K
----
24.03%-196.00K
----
-98.92%2.37M
-100.51%-252.00K
13.13%-258.00K
57.58%-1.22M
14.61%219.30M
--49.60M
---297.00K
-2125.58%-2.87M

FAQs

What is the total revenue of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its total revenue reached 81.36M, with a year-on-year change of 70.84M.

What are the current assets of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its current assets were 306.33M, with a year-on-year change of -0.34.

What are the total assets of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its total assets of ADC Therapeutics SA were 323.15M, with a year-on-year change of 0.36.

What are the total liabilities of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its total liabilities of ADC Therapeutics SA were 508.98M, with a year-on-year change of -2.98.

What is the total equity of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its total equity of ADC Therapeutics SA was -185.83M, with a year-on-year change of 8.29.

What is the net operating income of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its net operating income of ADC Therapeutics SA was -108.38M, with a year-on-year change of 17.05.

What is the net investment of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its net investment of ADC Therapeutics SA was 395.00K, with a year-on-year change of 145.56.

What is the net financing of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its net financing of ADC Therapeutics SA was 150.94M, with a year-on-year change of 55.53.

What is the Earnings Per Share (EPS) of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its Earnings Per Share (EPS) was -1.12, with a year-on-year change of 30.91.

What is the net income of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its net income was -142.62M, with a year-on-year change of 9.64.

What is the net margin of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its net profit margin was -175.31, with a year-on-year change of 21.33.

What is the gross margin of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its gross margin was 92.87, with a year-on-year change of 1.39.

What is the debt-to-asset ratio of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its debt-to-asset ratio was 135.53, with a year-on-year change of 0.61.

What is the Return on Assets (ROA) of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its Return on Assets (ROA) was -44.22, with a year-on-year change of 5.21.

What is the operating profit of ADC Therapeutics SA?

According to ADC Therapeutics SA's FY2025 earnings report, its operating profit was -108.38M, with a year-on-year change of 17.05.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.